November 10, 2020
BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled “Method and kit for detection of cell mediated immune response” related to the potential […]
